Every material Form 8-K IonQ, Inc. has filed with the SEC since October 13, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
IonQ reported third-quarter 2026 revenue of $173.8 million, up 336% year over year, and raised its full-year 2026 revenue guidance to $505 million to $515 million. The company also reported GAAP net income of $564.0 million, driven by a non-cash warrant fair value gain, while Adjusted EPS was a loss of $0.29 and Adjusted EBITDA was a loss of $133.6 million; the same day it completed the Elisity acquisition, issuing 32,233,274 shares at closing.
Q3 2026 revenue was $173.8 million, up 336% year over year; the company said it was its sixth consecutive record quarter.
Full-year 2026 revenue guidance raised to $505 million to $515 million.
GAAP net income attributable to IonQ was $564.0 million (GAAP EPS $1.42), reflecting a warrant fair value gain; Adjusted EPS was ($0.29) versus ($0.17) a year earlier, and Adjusted EBITDA loss was ($133.6) million.
Elisity acquisition closed November 3, 2026, with 32,233,274 shares issued at closing and up to 36,499,208 shares in total including earn-out.
IonQ entered into an underwriting agreement on October 14, 2026 with J.P. Morgan Securities LLC for a sale of 20.5 million common shares, 29.5 million pre-funded warrants and 100 million Series C warrants, with each share or pre-funded warrant offered with two Series C warrants at a combined price of $40.00. The offering closed on October 16, 2026. The filing shows the new shares and warrants add potential dilution for existing shareholders, and the Series C warrants can be exercised at $69.46 per share for up to seven years.
Offering closed October 16, 2026, after an underwriting agreement dated October 14, 2026 with J.P. Morgan Securities LLC as sole underwriter
Offered 20.5 million common shares and 29.5 million pre-funded warrants, each paired with two Series C warrants, at a combined price of $40.00
Series C warrants total 100 million, with an exercise price of $69.46 per share and a term through the seven-year anniversary of issuance
Warrants were issued under agreements dated October 16, 2026 with Continental Stock Transfer & Trust Company as warrant agent
IonQ signed a merger agreement on October 9, 2026 to acquire all outstanding shares of Elisity, Inc., a Zero Trust security company, paying in IonQ common stock. The closing consideration is set at $1.15 billion, with up to $150 million more in earnout shares tied to Elisity revenue milestones through January 31, 2028. Shareholders will see new shares issued at closing, and the deal is expected to close in the fourth quarter of 2026, subject to regulatory approvals.
Closing consideration of $1,150,000,000 in IonQ shares, plus up to $150,000,000 in earnout shares based on Elisity revenue milestones from August 1, 2026 to January 31, 2028
Share price used for issuance is capped between $33.07 and $49.61 per share
Separate retention pool of RSUs valued at $100,000,000, vesting over four years
Expected to close in fourth quarter 2026; either party may terminate if closing has not occurred by January 7, 2027
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every IonQ, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →